The company says its lower-cost treatment could help it compete in emerging markets across West Asia and Asia-Pacific.
Immuneel eyes West Asia, Asia-Pacific expansion for cancer therapy after ₹100 crore funding
The company says its lower-cost treatment could help it compete in emerging markets across West Asia and Asia-Pacific.
